For: |
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Fourteen- |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i26/8132.htm |
Number | Citing Articles |
1 |
Neus Muñoz, Jordi Sánchez-Delgado, Mireia Baylina, Ignasi Puig, Sheila López-Góngora, David Suarez, Xavier Calvet. Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori
. Helicobacter 2018; 23(3): e12488 doi: 10.1111/hel.12488
|
2 |
Sung Bum Kim, Si Hyung Lee, Kyeong Ok Kim, Byung Ik Jang, Tae Nyeun Kim. Ten-day Sequential TherapyversusBismuth Based Quadruple Therapy as Second Line Treatment forHelicobacter pyloriInfection. The Korean Journal of Gastroenterology 2015; 66(5): 261 doi: 10.4166/kjg.2015.66.5.261
|
3 |
Pei‐Ying Zou, Jie Hu, Jing‐Tao Zhao, Zhe Zhao, Hao Mei, Jing Yang, Yang‐Jie Zhu, Yi Zhang, Chun‐Hui Lan.
10‐Day and 14‐day high‐dose dual therapy for the treatment of
Helicobacter pylori
: A propensity score matching analysis
. Helicobacter 2021; 26(5) doi: 10.1111/hel.12833
|
4 |
Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Hae Koo Kim, Young Dal Lee. Second-line bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> eradication and impact of diabetes. World Journal of Gastroenterology 2017; 23(6): 1059-1066 doi: 10.3748/wjg.v23.i6.1059
|
5 |
Pedro Cortés, Alfred D. Nelson, Yan Bi, Fernando F. Stancampiano, Loren P. Murray, George G.A. Pujalte, Victoria Gomez, Dana M. Harris. Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review. Journal of Primary Care & Community Health 2021; 12: 215013272110140 doi: 10.1177/21501327211014087
|
6 |
Varocha Mahachai, Ratha-korn Vilaichone, Rapat Pittayanon, Jarin Rojborwonwitaya, Somchai Leelakusolvong, Monthira Maneerattanaporn, Peranart Chotivitayatarakorn, Sombat Treeprasertsuk, Chomsri Kositchaiwat, Pises Pisespongsa, Pisaln Mairiang, Aziz Rani, Alex Leow, Swe Mon Mya, Yi-Chia Lee, Sengdao Vannarath, Bouachanh Rasachak, Oung Chakravuth, Moe Myint Aung, Tiing-Leong Ang, Jose D Sollano, Duc Trong Quach, Inchaya Sansak, Olarn Wiwattanachang, Piyathida Harnsomburana, Ari Fahrial Syam, Yoshio Yamaoka, Kwong-Ming Fock, Khean-Lee Goh, Kentaro Sugano, David Graham. Helicobacter pylorimanagement in ASEAN: The Bangkok consensus report. Journal of Gastroenterology and Hepatology 2018; 33(1): 37 doi: 10.1111/jgh.13911
|
7 |
Ji-Young Jeon, Sun-Young Kim, Seol Ju Moon, Kyeongmin Oh, Jiwon Lee, Bongtae Kim, Geun Seog Song, Min-Gul Kim. Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects. Clinical Therapeutics 2021; 43(4): 722 doi: 10.1016/j.clinthera.2021.01.026
|
8 |
Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh, Chul-Hyun Lim. Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication Rates. Journal of Clinical Medicine 2021; 10(15): 3273 doi: 10.3390/jcm10153273
|
9 |
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2018; 71(4): 196 doi: 10.4166/kjg.2018.71.4.196
|
10 |
Ji Yeon Kim, Sun-Young Lee, Hyobin Kim, Jeong Hwan Kim, In-Kyung Sung, Hyung Seok Park. Efficacy of Seven-Day Potassium-Competitive Acid Blocker-Based First-Line Helicobacter Pylori Eradication Therapy Administered with Bismuth. Yonsei Medical Journal 2021; 62(8): 708 doi: 10.3349/ymj.2021.62.8.708
|